[Intercellular adhesion molecules sICAM-1, sICAM-2, sICAM-3 and IFNgamma in neuroborreliosis and tick-borne encephalitis]

Przegl Epidemiol. 2006:60 Suppl 1:109-17.
[Article in Polish]

Abstract

Objective: The aim of this study was to evaluate the serum and CSF concentration of soluble intercellular adhesion molecules sICAM-1, sICAM-2, sICAM-3 and proinflammatory cytokine IFNgamma in patients with tick-borne encephalitis (TBE) and neuroborreliosis.

Methods: The study group consisted of 40: 20 with TBE meningitis and 20 with Lyme meningitis. The serum and CSF levels of adhesion molecules and IFNgamma were determined by ELISA assay twice: before and after treatment.

Results: Before treatment the concentrations of adhesion molecules and IFNgamma in serum as well as in CSF were significantly higher in both studied groups than in control group (with the exception of the serum level of sICAM-2 in TBE group). After the treatment, the serum parameters in TBE group decreased to the control level. CSF levels were also reduced, but still remained higher than in the control group. In patients with neuroborreliosis serum concentration of sICAM-1 and sICAM-2 did not change as compared with its level before treatment but other studied parameters in serum and CSF decreased significantly.

Conclusions: The results of our study confirm the participation of intercellular adhesion molecules in the pathogenesis of viral (TBE) and bacterial (neuroborreliosis) neuroinfections.

Publication types

  • Controlled Clinical Trial
  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antigens, CD / analysis*
  • Antigens, CD / blood
  • Antigens, CD / cerebrospinal fluid
  • Cell Adhesion Molecules / analysis*
  • Cell Adhesion Molecules / blood
  • Cell Adhesion Molecules / cerebrospinal fluid
  • Encephalitis, Tick-Borne / blood*
  • Encephalitis, Tick-Borne / cerebrospinal fluid*
  • Encephalitis, Tick-Borne / drug therapy
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Interleukin-18 / blood
  • Interleukin-18 / cerebrospinal fluid
  • Lyme Neuroborreliosis / blood*
  • Lyme Neuroborreliosis / cerebrospinal fluid*
  • Lyme Neuroborreliosis / drug therapy
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Antigens, CD
  • Cell Adhesion Molecules
  • ICAM2 protein, human
  • ICAM3 protein, human
  • Interleukin-18